{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T14:03:22Z","timestamp":1771682602941,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Health Econ Health Policy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s40258-025-01007-1","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T13:26:19Z","timestamp":1759843579000},"page":"287-292","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Role of Price Variation in Economic Analyses for Cancer Screenings: A Rapid Review"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0899-7565","authenticated-orcid":false,"given":"Austin J.","family":"Triana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mason N.","family":"Alford-Holloway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"1007_CR1","unstructured":"Amin K, Ortaliza J, Cox C, Wager E. Health care costs and affordability. KFF; 2024. https:\/\/www.kff.org\/health-policy-101-health-care-costs-and-affordability\/?entry=table-of-contents-what-factors-contribute-to-u-s-health-care-spending"},{"key":"1007_CR2","doi-asserted-by":"publisher","first-page":"E639","DOI":"10.1001\/amajethics.2021.639","volume":"23","author":"D Kim","year":"2021","unstructured":"Kim D, Basu A. How does cost-effectiveness analysis inform health care decisions? AMA J Ethics. 2021;23:E639-647. https:\/\/doi.org\/10.1001\/amajethics.2021.639.","journal-title":"AMA J Ethics"},{"key":"1007_CR3","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.19.02757","volume":"38","author":"EJ Trabulsi","year":"2020","unstructured":"Trabulsi EJ, Rumble RB, Jadvar H, Hope T, Pomper M, Turkbey B, et al. Optimum imaging strategies for advanced prostate cancer: ASCO guideline. JCO. 2020;38:1963\u201396. https:\/\/doi.org\/10.1200\/JCO.19.02757.","journal-title":"JCO"},{"key":"1007_CR4","doi-asserted-by":"publisher","unstructured":"Wheeler C, Taylor R. New Year, New CMS price transparency rule for hospitals 2021. Health Affairs Forefront. https:\/\/doi.org\/10.1377\/forefront.20210112.545531.","DOI":"10.1377\/forefront.20210112.545531"},{"key":"1007_CR5","doi-asserted-by":"publisher","first-page":"11055","DOI":"10.1200\/JCO.2024.42.16_suppl.11055","volume":"42","author":"M Alford","year":"2024","unstructured":"Alford M, Triana A, Baker K, Trivedi Y, Mullangi S, Van Horn L. Assessing the true cost of cancer screening: comparing hospital prices to claims remittance data for common cancer screening tests at top-ranked US hospitals. J Clin Oncol. 2024;42:11055\u201311055. https:\/\/doi.org\/10.1200\/JCO.2024.42.16_suppl.11055.","journal-title":"J Clin Oncol"},{"key":"1007_CR6","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/MLR.0000000000001506","volume":"59","author":"N Kunst","year":"2021","unstructured":"Kunst N, Long JB, Xu X, Busch SH, Kyanko KA, Lindau ST, et al. Understanding regional variation in the cost of breast cancer screening among privately insured women in the United States. Med Care. 2021;59:437\u201343. https:\/\/doi.org\/10.1097\/MLR.0000000000001506.","journal-title":"Med Care"},{"key":"1007_CR7","doi-asserted-by":"publisher","DOI":"10.1161\/circ.150.suppl_1.4136705","author":"A Triana","year":"2024","unstructured":"Triana A, Van Horn R, Alford M, Quintana J, Van Horn R. Complexity and inconsistency of echocardiogram prices at top-rated hospitals in the United States. Circulation. 2024. https:\/\/doi.org\/10.1161\/circ.150.suppl_1.4136705.","journal-title":"Circulation"},{"key":"1007_CR8","unstructured":"Leading Causes of Death. CDC\/National Center for Health Statistics; n.d. https:\/\/www.cdc.gov\/nchs\/fastats\/leading-causes-of-death.htm"},{"key":"1007_CR9","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.7326\/M24-0375","volume":"177","author":"MT Halpern","year":"2024","unstructured":"Halpern MT, Liu B, Lowy DR, Gupta S, Croswell JM, Doria-Rose VP. The annual cost of cancer screening in the United States. Ann Intern Med. 2024;177:1170\u20138. https:\/\/doi.org\/10.7326\/M24-0375.","journal-title":"Ann Intern Med"},{"key":"1007_CR10","unstructured":"Triana AJ, Hatcher LA, Koester S, Iacobucci D, Laffer AB, Horn RLV. Ignorance is not Bliss: discordant beliefs and preferences for prices among healthcare consumers in the United States. Health Manage Policy Innov. 2022;7."},{"key":"1007_CR11","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1161\/CIR.0000000000000549","volume":"2018","author":"SM Al-Khatib","year":"2017","unstructured":"Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2017;2018:138. https:\/\/doi.org\/10.1161\/CIR.0000000000000549.","journal-title":"Circulation"},{"key":"1007_CR12","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1161\/01.CIR.97.21.2129","volume":"97","author":"AI Mushlin","year":"1998","unstructured":"Mushlin AI, Hall WJ, Zwanziger J, Gajary E, Andrews M, Marron R, et al. The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Circulation. 1998;97:2129\u201335. https:\/\/doi.org\/10.1161\/01.CIR.97.21.2129.","journal-title":"Circulation"},{"key":"1007_CR13","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1161\/01.CIR.0000015504.57641.D0","volume":"105","author":"G Larsen","year":"2002","unstructured":"Larsen G, Hallstrom A, McAnulty J, Pinski S, Olarte A, Sullivan S, et al. Cost-effectiveness of the implantable cardioverter-defibrillator versus antiarrhythmic drugs in survivors of serious ventricular tachyarrhythmias: results of the Antiarrhythmics Versus Implantable Defibrillators (AVID) economic analysis substudy. Circulation. 2002;105:2049\u201357. https:\/\/doi.org\/10.1161\/01.CIR.0000015504.57641.D0.","journal-title":"Circulation"},{"key":"1007_CR14","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1016\/j.jacc.2006.03.032","volume":"47","author":"J Zwanziger","year":"2006","unstructured":"Zwanziger J, Hall WJ, Dick AW, Zhao H, Mushlin AI, Hahn RM, et al. The cost effectiveness of implantable cardioverter-defibrillators. J Am Coll Cardiol. 2006;47:2310\u20138. https:\/\/doi.org\/10.1016\/j.jacc.2006.03.032.","journal-title":"J Am Coll Cardiol"},{"key":"1007_CR15","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1001\/jamainternmed.2022.2602","volume":"182","author":"AS Oseran","year":"2022","unstructured":"Oseran AS, Ati S, Feldman WB, Gondi S, Yeh RW, Wadhera RK. Assessment of prices for cardiovascular tests and procedures at top-ranked US hospitals. JAMA Intern Med. 2022;182:996. https:\/\/doi.org\/10.1001\/jamainternmed.2022.2602.","journal-title":"JAMA Intern Med"},{"key":"1007_CR16","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.xjon.2022.03.009","volume":"10","author":"J Hadaya","year":"2022","unstructured":"Hadaya J, Sanaiha Y, Tran Z, Shemin RJ, Benharash P. Defining value in cardiac surgery: a contemporary analysis of cost variation across the United States. JTCVS Open. 2022;10:266\u201381. https:\/\/doi.org\/10.1016\/j.xjon.2022.03.009.","journal-title":"JTCVS Open"},{"key":"1007_CR17","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1097\/XCS.0000000000001157","volume":"239","author":"J Sanchez","year":"2024","unstructured":"Sanchez J, Lundberg A, Jones W, Valukas C, Lagu T, Teitelbaum E, et al. Comparative cost-effectiveness analysis of bariatric surgery and GLP-1 receptor agonists for the management of obesity. J Am Coll Surg. 2024;239:S21-46. https:\/\/doi.org\/10.1097\/XCS.0000000000001157.","journal-title":"J Am Coll Surg"},{"key":"1007_CR18","doi-asserted-by":"publisher","first-page":"4061","DOI":"10.1177\/00031348231177937","volume":"89","author":"AP Ng","year":"2023","unstructured":"Ng AP, Bakhtiyar SS, Verma A, Richardson S, Kronen E, Darbinian K, et al. Cost variation in bariatric surgery across the United States. Am Surg. 2023;89:4061\u20135. https:\/\/doi.org\/10.1177\/00031348231177937.","journal-title":"Am Surg"},{"key":"1007_CR19","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s11606-011-1721-x","volume":"26","author":"R Padwal","year":"2011","unstructured":"Padwal R, Klarenbach S, Wiebe N, Hazel M, Birch D, Karmali S, et al. Bariatric surgery: a systematic review of the clinical and economic evidence. J Gen Intern Med. 2011;26:1183\u201394. https:\/\/doi.org\/10.1007\/s11606-011-1721-x.","journal-title":"J Gen Intern Med"},{"key":"1007_CR20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/jhm.12969","volume":"18","author":"W Levinson","year":"2023","unstructured":"Levinson W, Leis JA. Improving healthcare value: lessons learned from the first decade of Choosing Wisely. J Hosp Med. 2023;18:78\u201381. https:\/\/doi.org\/10.1002\/jhm.12969.","journal-title":"J Hosp Med"},{"key":"1007_CR21","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1038\/s41416-021-01498-4","volume":"125","author":"A Hackshaw","year":"2021","unstructured":"Hackshaw A, Cohen SS, Reichert H, Kansal AR, Chung KC, Ofman JJ. Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK. Br J Cancer. 2021;125:1432\u201342. https:\/\/doi.org\/10.1038\/s41416-021-01498-4.","journal-title":"Br J Cancer"},{"key":"1007_CR22","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1093\/jnci\/djae124","volume":"116","author":"P Nascimento De Lima","year":"2024","unstructured":"Nascimento De Lima P, Van Den Puttelaar R, Knudsen AB, Hahn AI, Kuntz KM, Ozik J, et al. Characteristics of a cost-effective blood test for colorectal cancer screening. JNCI J Natl Cancer Inst. 2024;116:1612\u201320. https:\/\/doi.org\/10.1093\/jnci\/djae124.","journal-title":"JNCI J Natl Cancer Inst"},{"key":"1007_CR23","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1001\/jama.2016.12195","volume":"316","author":"GD Sanders","year":"2016","unstructured":"Sanders GD, Neumann PJ, Basu A, Brock DW, Feeny D, Krahn M, et al. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. JAMA. 2016;316:1093. https:\/\/doi.org\/10.1001\/jama.2016.12195.","journal-title":"JAMA"},{"key":"1007_CR24","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1093\/aje\/kwab155","volume":"190","author":"N Hendrix","year":"2021","unstructured":"Hendrix N, Gulati R, Jiao B, Kader AK, Ryan ST, Etzioni R. Clarifying the trade-offs of risk-stratified screening for prostate cancer: a cost-effectiveness study. Am J Epidemiol. 2021;190:2064\u201374. https:\/\/doi.org\/10.1093\/aje\/kwab155.","journal-title":"Am J Epidemiol"},{"key":"1007_CR25","doi-asserted-by":"publisher","first-page":"871","DOI":"10.7326\/M23-1504","volume":"177","author":"R Gulati","year":"2024","unstructured":"Gulati R, Jiao B, Al-Faouri R, Sharma V, Kaul S, Fleishman A, et al. Lifetime health and economic outcomes of biparametric magnetic resonance imaging as first-line screening for prostate cancer: a decision model analysis. Ann Intern Med. 2024;177:871\u201381. https:\/\/doi.org\/10.7326\/M23-1504.","journal-title":"Ann Intern Med"},{"key":"1007_CR26","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/jnci\/djab149","volume":"114","author":"JM Yeh","year":"2022","unstructured":"Yeh JM, Lowry KP, Schechter CB, Diller LR, O\u2019Brien G, Alagoz O, et al. Breast cancer screening among childhood cancer survivors treated without chest radiation: clinical benefits and cost-effectiveness. J Natl Cancer Inst. 2022;114:235\u201344. https:\/\/doi.org\/10.1093\/jnci\/djab149.","journal-title":"J Natl Cancer Inst"},{"key":"1007_CR27","doi-asserted-by":"publisher","first-page":"602","DOI":"10.7326\/M20-2912","volume":"174","author":"Y-CT Shih","year":"2021","unstructured":"Shih Y-CT, Dong W, Xu Y, Etzioni R, Shen Y. Incorporating baseline breast density when screening women at average risk for breast cancer: a cost-effectiveness analysis. Ann Internal Med. 2021;174:602\u201312. https:\/\/doi.org\/10.7326\/M20-2912.","journal-title":"Ann Internal Med"},{"key":"1007_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.7326\/M20-8076","volume":"175","author":"JT Schousboe","year":"2022","unstructured":"Schousboe JT, Sprague BL, Abraham L, O\u2019Meara ES, Onega T, Advani S, et al. Cost-effectiveness of screening mammography beyond age 75 years: a cost-effectiveness analysis. Ann Intern Med. 2022;175:11\u20139. https:\/\/doi.org\/10.7326\/M20-8076.","journal-title":"Ann Intern Med"},{"key":"1007_CR29","doi-asserted-by":"publisher","first-page":"320","DOI":"10.7326\/M22-2216","volume":"176","author":"I Toumazis","year":"2023","unstructured":"Toumazis I, Cao P, de Nijs K, Bastani M, Munshi V, Hemmati M, et al. Risk model-based lung cancer screening\u202f: a cost-effectiveness analysis. Ann Intern Med. 2023;176:320\u201332. https:\/\/doi.org\/10.7326\/M22-2216.","journal-title":"Ann Intern Med"},{"key":"1007_CR30","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1001\/jamaoncol.2021.4942","volume":"7","author":"I Toumazis","year":"2021","unstructured":"Toumazis I, de Nijs K, Cao P, Bastani M, Munshi V, Ten Haaf K, et al. Cost-effectiveness evaluation of the 2021 US Preventive Services Task Force recommendation for lung cancer screening. JAMA Oncol. 2021;7:1833\u201342. https:\/\/doi.org\/10.1001\/jamaoncol.2021.4942.","journal-title":"JAMA Oncol"},{"key":"1007_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkab081","volume":"5","author":"I Toumazis","year":"2021","unstructured":"Toumazis I, Erdogan SA, Bastani M, Leung A, Plevritis SK. A cost-effectiveness analysis of lung cancer screening with low-dose computed tomography and a diagnostic biomarker. JNCI Cancer Spectr. 2021;5:pkab081. https:\/\/doi.org\/10.1093\/jncics\/pkab081.","journal-title":"JNCI Cancer Spectr"},{"key":"1007_CR32","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jval.2023.12.014","volume":"27","author":"J Shafrin","year":"2024","unstructured":"Shafrin J, Kim J, Marin M, Ramsagar S, Davies ML, Stewart K, et al. Quantifying the value of reduced health disparities: low-dose computed tomography lung cancer screening of high-risk individuals within the United States. Value Health. 2024;27:313\u201321. https:\/\/doi.org\/10.1016\/j.jval.2023.12.014.","journal-title":"Value Health"},{"key":"1007_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12102326","volume":"12","author":"M Mascalchi","year":"2022","unstructured":"Mascalchi M, Picozzi G, Puliti D, Gorini G, Mantellini P, Sali L. Single CT appointment for double lung and colorectal cancer screening: is the time ripe? Diagnostics (Basel). 2022;12:2326. https:\/\/doi.org\/10.3390\/diagnostics12102326.","journal-title":"Diagnostics (Basel)"},{"key":"1007_CR34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12890-021-01805-y","volume":"22","author":"A Kowada","year":"2022","unstructured":"Kowada A. Cost-effectiveness and health impact of lung cancer screening with low-dose computed tomography for never smokers in Japan and the United States: a modelling study. BMC Pulm Med. 2022;22:19. https:\/\/doi.org\/10.1186\/s12890-021-01805-y.","journal-title":"BMC Pulm Med"},{"key":"1007_CR35","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1053\/j.gastro.2024.02.012","volume":"167","author":"R van den Puttelaar","year":"2024","unstructured":"van den Puttelaar R, Nascimento de Lima P, Knudsen AB, Rutter CM, Kuntz KM, de Jonge L, et al. Effectiveness and cost-effectiveness of colorectal cancer screening with a blood test that meets the centers for medicare & medicaid services coverage decision. Gastroenterology. 2024;167:368\u201377. https:\/\/doi.org\/10.1053\/j.gastro.2024.02.012.","journal-title":"Gastroenterology"},{"key":"1007_CR36","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/jnci\/djaa103","volume":"113","author":"EFP Peterse","year":"2021","unstructured":"Peterse EFP, Meester RGS, de Jonge L, Omidvari A-H, Alarid-Escudero F, Knudsen AB, et al. Comparing the cost-effectiveness of innovative colorectal cancer screening tests. J Natl Cancer Inst. 2021;113:154\u201361. https:\/\/doi.org\/10.1093\/jnci\/djaa103.","journal-title":"J Natl Cancer Inst"},{"key":"1007_CR37","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.gie.2021.02.013","volume":"94","author":"A Deibel","year":"2021","unstructured":"Deibel A, Deng L, Cheng C-Y, Schlander M, Ran T, Lang B, et al. Evaluating key characteristics of ideal colorectal cancer screening modalities: the microsimulation approach. Gastrointest Endosc. 2021;94:379-390.e7. https:\/\/doi.org\/10.1016\/j.gie.2021.02.013.","journal-title":"Gastrointest Endosc"}],"container-title":["Applied Health Economics and Health Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-025-01007-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40258-025-01007-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-025-01007-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T13:15:28Z","timestamp":1771679728000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40258-025-01007-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1007"],"URL":"https:\/\/doi.org\/10.1007\/s40258-025-01007-1","relation":{},"ISSN":["1175-5652","1179-1896"],"issn-type":[{"value":"1175-5652","type":"print"},{"value":"1179-1896","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"assertion":[{"value":"17 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no potential conflicts of interest to disclose. Generative AI tools such as ChatGPT were used for ideation and grammatical proofreading, and they were not used in any part of writing, editing, or analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}